Ranson Criteria
The original prognostic scoring system for acute pancreatitis, using 11 clinical and laboratory parameters assessed at admission and at 48 hours to estimate disease severity and in-hospital mortality.
Calculate Ranson Score
Select the pancreatitis aetiology (non-gallstone or gallstone), then enter the patient’s data. The score uses 5 criteria at admission and 6 criteria at 48 hours (5 for gallstone). You may calculate with admission data alone for an early estimate, or enter the full set once 48-hour values are available.
Phase 2 — At 48 Hours
Ranson criteria require 48 hours for complete scoring — 5 parameters at admission and 6 at 48 hours (5 for gallstone pancreatitis). You can calculate an admission-only partial score by leaving the 48-hour fields blank, but the full score is only meaningful once both phases are complete. For immediate bedside prognostication, consider the BISAP score, which can be completed within the first 24 hours.
Understanding Ranson Criteria
The Ranson criteria were developed by John H.C. Ranson at New York University in 1974 and represent the first widely adopted prognostic scoring system for acute pancreatitis. Ranson studied 100 consecutive patients with acute pancreatitis and identified 11 clinical and laboratory parameters that independently predicted mortality.
The score was originally developed for alcohol-related pancreatitis. In 1982, Ranson published a modified version with different thresholds for gallstone pancreatitis, reflecting the different pathophysiology and patient demographics. The two-phase design — admission and 48-hour parameters — reflects the evolving nature of acute pancreatitis and the importance of the patient’s trajectory over the first two days.
Non-Gallstone Criteria
AT ADMISSION (5 criteria)
- Age > 55 years
- WBC > 16,000/µL
- Blood glucose > 200 mg/dL
- LDH > 350 IU/L
- AST > 250 IU/L
AT 48 HOURS (6 criteria)
- Haematocrit drop > 10%
- BUN rise > 5 mg/dL
- Calcium < 8 mg/dL
- PaO₂ < 60 mmHg
- Base deficit > 4 mEq/L
- Fluid sequestration > 6 L
Total possible: 11 points
Gallstone Criteria
AT ADMISSION (5 criteria)
- Age > 70 years
- WBC > 18,000/µL
- Blood glucose > 220 mg/dL
- LDH > 400 IU/L
- AST > 250 IU/L
AT 48 HOURS (5 criteria)
- Haematocrit drop > 10%
- BUN rise > 2 mg/dL
- Calcium < 8 mg/dL
- Base deficit > 5 mEq/L
- Fluid sequestration > 4 L
Total possible: 10 points (no PaO₂)
Key distinction: The gallstone version has different thresholds for four of the five admission criteria (age, WBC, glucose, LDH) and three of the 48-hour criteria (BUN rise, base deficit, fluid sequestration), and does not include PaO₂. Always select the correct aetiology — using the wrong set of thresholds produces an incorrect score.
Interpretation & Mortality Estimates
The Ranson score stratifies patients into severity categories with progressively increasing mortality risk. The critical threshold is a score of ≥ 3, which historically defines “severe” acute pancreatitis and triggers consideration for intensive monitoring.
| Ranson Score | Severity | Estimated Mortality | Clinical Implication |
|---|---|---|---|
| 0–2 | Mild | ~2% (effectively minimal) | Ward-level care; supportive management; excellent prognosis |
| 3–4 | Moderate | ~15% | Consider step-down/HDU monitoring; aggressive resuscitation; gastroenterology input |
| 5–6 | Severe | ~40% | ICU admission recommended; anticipate organ failure; multidisciplinary management |
| ≥ 7 | Critical | Approaching 100% | ICU mandatory; maximal organ support; early goals-of-care discussions |
The original mortality estimates from Ranson’s 1974 study were derived from a relatively small cohort and likely overestimate mortality in modern practice. Advances in ICU care, fluid resuscitation, minimally invasive interventions, and nutritional support have significantly improved survival rates in severe pancreatitis. Contemporary studies suggest actual mortality at each score level is lower than the original estimates — but the relative risk stratification (higher score = worse prognosis) remains valid and clinically useful.
The admission-only partial score (0–5) provides useful early prognostic information even before the 48-hour criteria are available. An admission score of ≥ 3 already suggests a high-risk patient who may warrant early escalation, even before the full 48-hour score is calculated. However, the BISAP score is a simpler and equally validated alternative for early risk stratification within the first 24 hours.
Understanding the Individual Criteria
Each Ranson criterion captures a specific dimension of pancreatitis pathophysiology. The admission criteria reflect the severity of the initial inflammatory insult, while the 48-hour criteria capture the systemic consequences of ongoing inflammation, third-spacing, and early organ dysfunction.
Age reflects reduced physiological reserve and higher comorbidity burden. The different thresholds (55 for non-gallstone, 70 for gallstone) reflect the older age distribution of gallstone pancreatitis compared to alcoholic pancreatitis.
WBC count reflects the intensity of the acute inflammatory response. A markedly elevated WBC suggests a vigorous systemic response to pancreatic injury, which is associated with worse outcomes. Gallstone pancreatitis uses a higher threshold (18,000 vs 16,000) because biliary tract inflammation may contribute to leukocytosis independently of pancreatitis severity.
Blood glucose elevation indicates stress hyperglycaemia (driven by catecholamine and cortisol release) and/or direct damage to pancreatic islet cells. Glucose values above the threshold suggest more extensive pancreatic parenchymal injury affecting both exocrine and endocrine function.
LDH (lactate dehydrogenase) is a non-specific marker of tissue injury and cellular necrosis. Elevated LDH at admission reflects the severity of the initial pancreatic insult and possibly early ischaemic tissue injury.
AST (aspartate aminotransferase) elevation reflects hepatocellular injury, which in pancreatitis may result from direct biliary obstruction (gallstone pancreatitis), hepatic congestion, or ischaemia. The threshold of > 250 IU/L is the same for both aetiologies.
Haematocrit drop > 10% reflects significant intravascular volume loss from third-spacing of fluid into the retroperitoneum, peritoneal cavity, and interstitial space. A falling haematocrit despite fluid resuscitation suggests ongoing capillary leak and potentially haemorrhagic complications.
BUN rise reflects ongoing prerenal azotaemia despite resuscitation — either from inadequate fluid replacement or overwhelming third-spacing. The different thresholds (> 5 mg/dL for non-gallstone, > 2 mg/dL for gallstone) reflect different sensitivity to renal hypoperfusion in these populations.
Serum calcium < 8 mg/dL is multifactorial: saponification of retroperitoneal and mesenteric fat sequesters calcium, hypoalbuminaemia reduces total calcium levels, and direct effects of circulating inflammatory mediators on parathyroid function may contribute. Hypocalcaemia is a marker of more extensive fat necrosis.
PaO₂ < 60 mmHg (non-gallstone only) reflects the development of acute lung injury, ranging from pleural effusion and atelectasis to full ARDS. Systemic inflammatory mediators increase pulmonary capillary permeability, and diaphragmatic splinting from abdominal pain reduces ventilatory function. This is one of the earliest and most common organ failures in severe pancreatitis.
Base deficit > 4–5 mEq/L reflects tissue hypoperfusion and anaerobic metabolism. A metabolic acidosis developing over the first 48 hours suggests systemic shock physiology, with inadequate oxygen delivery to meet tissue demands.
Fluid sequestration > 4–6 L is defined as the estimated net volume of fluid trapped in third spaces (calculated as total IV fluid input minus total urine output and other measurable losses). Massive third-spacing indicates severe capillary leak, retroperitoneal inflammation, and potentially the development of pancreatic and peripancreatic fluid collections.
Ranson observed that gallstone pancreatitis and alcoholic/other pancreatitis have different baseline clinical profiles. Gallstone pancreatitis patients tend to be older, predominantly female, and present with higher baseline biliary enzyme levels. Alcoholic pancreatitis patients tend to be younger, predominantly male, and present with more pronounced inflammatory markers.
The modified gallstone thresholds reflect these demographic and pathophysiological differences. For example, the age threshold is 70 (vs 55) because gallstone pancreatitis occurs in an older population where age carries less discriminatory power at a lower cut-off. The WBC threshold is 18,000 (vs 16,000) because biliary inflammation itself may elevate the WBC, requiring a higher threshold to identify pancreatitis-specific leukocytosis. PaO₂ was excluded from the gallstone criteria because it did not independently predict mortality in the gallstone cohort.
Special Populations
Anticoagulation (warfarin, DOACs, heparin) may affect the haematocrit criterion independently of third-spacing. A haematocrit drop in an anticoagulated patient may represent retroperitoneal haemorrhage rather than capillary leak, which has a different clinical significance and management pathway. Consider cross-sectional imaging if there is a disproportionate haematocrit drop in anticoagulated patients.
Patients with COPD or other chronic respiratory conditions may have a baseline PaO₂ below 60 mmHg on room air, which would automatically score a point on the non-gallstone criteria regardless of pancreatitis severity. In these patients, a decline from their known baseline PaO₂ is more meaningful than an absolute threshold. This is not accounted for in the standard scoring system.
Chronic alcohol use may independently affect several Ranson parameters: baseline macrocytosis can artificially elevate haematocrit; chronic liver disease may affect LDH, AST, and albumin levels; and nutritional deficiency may produce baseline hypocalcaemia. In patients with known alcoholic liver disease, interpret admission LDH and AST elevations carefully — they may reflect chronic hepatic injury rather than pancreatitis severity alone.
Diabetic patients may present with elevated blood glucose from pre-existing insulin resistance or treatment non-adherence rather than pancreatitis-induced stress hyperglycaemia. A glucose of 220 mg/dL in a patient with uncontrolled type 2 diabetes has a different prognostic significance than the same value in a previously normoglycaemic individual. Consider the change from the patient’s known baseline glucose rather than the absolute value.
Ranson vs Other Pancreatitis Severity Scores
The Ranson criteria were the first pancreatitis severity scoring system and have been the benchmark against which all subsequent tools have been compared. Understanding the strengths and limitations of each approach helps guide clinical decision-making.
| Feature | Ranson | BISAP | APACHE II | Revised Atlanta |
|---|---|---|---|---|
| Year introduced | 1974 | 2008 | 1985 (adapted) | 2012 |
| Parameters | 11 (5 + 6) | 5 | 14 | Clinical outcomes |
| Time to complete | 48 hours | 24 hours | 24 hours | Retrospective |
| Labs required | Yes (extensive) | Yes (BUN, WBC) | Yes (ABG, extensive) | Organ failure criteria |
| Serial recalculation | No | No | Yes (daily) | Ongoing classification |
| Key advantage | Widely known; historical benchmark | Simple; fast; validated in large cohorts | Most discriminating; serial use | Outcome-based; consensus standard |
| Key limitation | 48h delay; cannot be repeated; outdated mortality estimates | Less granular than APACHE II | Complex; 14 variables; requires ABG | Retrospective — cannot guide early decisions |
Modern approach to pancreatitis severity assessment: Use BISAP at admission for rapid early stratification (complete within 24 hours). Assess SIRS persistence at 48 hours — transient SIRS vs persistent SIRS provides powerful prognostic information with minimal effort. Reserve Ranson criteria for institutions where they remain in local protocols and for comparison with historical literature. Use APACHE II for ICU patients where the full dataset is readily available and serial monitoring is needed. Classify final severity using the Revised Atlanta Classification for documentation and communication.
Common Pitfalls & Limitations
The most significant practical limitation of Ranson criteria is the requirement to wait 48 hours for the complete score. During this critical period, severe pancreatitis may already be producing organ failure, massive third-spacing, and respiratory compromise. Clinical decisions about ICU transfer, fluid management, and nutritional support cannot wait for the 48-hour score. This fundamental timing limitation is the primary reason newer tools (BISAP, APACHE II) have been developed and are increasingly preferred.
If using Ranson criteria, treat the admission score as an early warning: an admission score of ≥ 3/5 should prompt immediate escalation without waiting for the 48-hour parameters.
The non-gallstone and gallstone versions have different thresholds for 7 of the 11 criteria, and the gallstone version has only 10 criteria (no PaO₂). Using the non-gallstone thresholds for a patient with gallstone pancreatitis (or vice versa) will produce an incorrect score. This is particularly important for the BUN rise criterion, where the gallstone threshold (> 2 mg/dL) is much lower than the non-gallstone threshold (> 5 mg/dL) — a value of 3 mg/dL would be positive for gallstone but negative for non-gallstone pancreatitis.
If the aetiology is unknown at admission (which is not uncommon), the non-gallstone criteria are typically used as the default. Once aetiology is established (e.g., gallstones confirmed on ultrasound), the score should ideally be recalculated with the correct thresholds.
The original Ranson mortality estimates (0–2 → ~2%, 3–4 → ~15%, 5–6 → ~40%, ≥7 → ~100%) were derived from a 1974 cohort. Modern critical care, interventional radiology, minimally invasive necrosectomy, and improved nutritional support have substantially reduced pancreatitis mortality. Contemporary studies suggest actual mortality may be 30–50% lower at each score level than the original estimates. The score remains useful for relative risk stratification but the absolute mortality figures should be interpreted cautiously and communicated to patients and families with appropriate caveats.
Estimated fluid sequestration (> 6 L for non-gallstone, > 4 L for gallstone) is the most difficult criterion to assess accurately. It requires careful tracking of all fluid inputs (IV fluids, medications, blood products) and outputs (urine, nasogastric drainage, drain output) over 48 hours, with the difference representing “sequestered” fluid. In practice, this calculation is fraught with error: insensible losses are estimated, drain outputs may not capture all fluid, and IV fluid volumes may not be accurately documented.
Many institutions struggle with this criterion, and some clinicians omit it when data quality is poor — but this produces an incomplete score. If fluid balance documentation is unreliable, clearly note that the Ranson score is calculated without this criterion.
Unlike APACHE II, which can be recalculated daily to track a patient’s trajectory, the Ranson score is a one-time assessment. It captures the admission snapshot and the 48-hour change, but provides no framework for ongoing severity monitoring beyond this point. A patient whose condition improves dramatically after day 3 still carries their day-2 Ranson score. Similarly, a patient who was initially low-risk but deteriorates on day 5 (e.g., from infected necrosis) may have a misleadingly reassuring Ranson score from admission.
For ongoing prognostication beyond 48 hours, use clinical assessment, serial organ failure scoring (Modified Marshall Score), SIRS persistence, and imaging (CT severity index after 72+ hours).
Quick Reference Summary
| Score Range | Severity | Mortality (Historical) | Action |
|---|---|---|---|
| 0–2 | Mild | ~2% | Ward care; supportive management |
| 3–4 | Moderate | ~15% | Consider HDU/ICU; aggressive fluids |
| 5–6 | Severe | ~40% | ICU admission; anticipate organ failure |
| ≥ 7 | Critical | Approaching 100% | ICU mandatory; maximal support; GOC discussions |
The Golden Rule: Ranson criteria provide a severity estimate, not a treatment protocol. The score guides where to manage the patient (ward vs HDU vs ICU), not how to manage them. All acute pancreatitis patients — regardless of score — require IV fluids, analgesia, monitoring for organ failure, and investigation of the underlying cause. Do not let a low Ranson score delay appropriate supportive care.
Disclaimer & References
For Educational Purposes Only. This calculator and the accompanying clinical information are intended as educational tools for healthcare professionals. They do not replace clinical judgement. Results should be interpreted in the full clinical context. Lab reference ranges vary by institution — verify with your own laboratory. Drug dosages should be confirmed against current prescribing information.
References
- Ranson JH, Rifkind KM, Roses DF, Fink SD, Eng K, Spencer FC. Prognostic signs and the role of operative management in acute pancreatitis. Surg Gynecol Obstet. 1974;139(1):69–81. PMID: 4834279
- Ranson JH. Etiological and prognostic factors in human acute pancreatitis: a review. Am J Gastroenterol. 1982;77(9):633–638. PMID: 7051819
- Wu BU, Johannes RS, Sun X, Tabak Y, Conwell DL, Banks PA. The early prediction of mortality in acute pancreatitis: a large population-based study. Gut. 2008;57(12):1698–1703. DOI: 10.1136/gut.2008.152702
- Papachristou GI, Muddana V, Yadav D, et al. Comparison of BISAP, Ranson’s, APACHE-II, and CTSI scores in predicting organ failure, complications, and mortality in acute pancreatitis. Am J Gastroenterol. 2010;105(2):435–441. DOI: 10.1038/ajg.2009.622
- Banks PA, Bollen TL, Dervenis C, et al. Classification of acute pancreatitis — 2012: revision of the Atlanta classification and definitions by international consensus. Gut. 2013;62(1):102–111. DOI: 10.1136/gutjnl-2012-302779
- Tenner S, Baillie J, DeWitt J, Vege SS; American College of Gastroenterology. American College of Gastroenterology guideline: management of acute pancreatitis. Am J Gastroenterol. 2013;108(9):1400–1415. DOI: 10.1038/ajg.2013.218
- Mounzer R, Langmead CJ, Wu BU, et al. Comparison of existing clinical scoring systems to predict persistent organ failure in patients with acute pancreatitis. Gastroenterology. 2012;142(7):1476–1482. DOI: 10.1053/j.gastro.2012.03.005
- Cho JH, Kim TN, Chung HH, Kim KH. Comparison of scoring systems in predicting the severity of acute pancreatitis. World J Gastroenterol. 2015;21(8):2387–2394. DOI: 10.3748/wjg.v21.i8.2387
- De Bernardinis M, Violi V, Roncoroni L, Boselli AS, Giunta A, Peracchia A. Discriminant power and information content of Ranson’s prognostic signs in acute pancreatitis: a meta-analytic study. Crit Care Med. 1999;27(10):2272–2283. DOI: 10.1097/00003246-199910000-00031